The Middle East faces a dual health burden: noncommunicable diseases (NCDs) rising at unprecedented rates alongside infectious and emerging diseases influenced by climate change and population movement. This professional blog post synthesizes key data—including points from the provided document—and up-to-date sources, to serve decision-makers, healthcare professionals, and public health communicators.
Noncommunicable Diseases (NCDs)
Diabetes
The Middle East and North Africa (MENA) region has the highest regional prevalence of diabetes globally, with a projected steep rise in cases. Earlier estimates (2019) indicated about 12.2% prevalence, with growth expected through 2045. This matches the high rates noted in Gulf countries such as Saudi Arabia and the UAE.
Cardiovascular Diseases & Hypertension
Noncommunicable diseases account for more than half of deaths in the WHO Eastern Mediterranean Region, historically around 57% (2.2 million deaths annually). Lifestyle factors such as physical inactivity, diets high in sugar, salt, and trans fats, and smoking are major drivers.
Obesity
Globally, 1 in 8 people lived with obesity in 2022. The Middle East and North Africa have one of the fastest-growing burdens of obesity worldwide, which is strongly linked to diabetes, cardiovascular diseases, and some cancers.
Mental Health Disorders
Mental health disorders are rising, particularly in conflict-affected countries. WHO regional reports show progress in integrating services, but investment remains insufficient. The document provided noted the expected growth of the mental health services market through 2029.
Vitamin D Deficiency & Genetic Blood Disorders
Vitamin D deficiency is historically widespread in the region (30–90% depending on country and population group), though some countries show recent improvements—e.g., Saudi Arabia saw a drop from 32% in 2017 to 9% in 2020, then a slight rise to 18% in 2021. Thalassemia and sickle cell anemia remain common in several Arab and Gulf states.
Infectious and Emerging Diseases
Middle East Respiratory Syndrome (MERS-CoV)
A zoonotic virus primarily transmitted from dromedary camels to humans, with human-to-human spread in close contact and healthcare settings. Animal reservoirs are documented across parts of the Middle East, Africa, and Asia. Vigilance is particularly necessary in Arabian Peninsula countries.
Vector-Borne Diseases
Dengue fever is expanding from 2017 to 2023, the number of Eastern Mediterranean countries reporting outbreaks rose from 3 to 12, making it the fastest-spreading mosquito-borne disease globally. Cutaneous leishmaniasis is highly concentrated in the region, with visceral leishmaniasis in focal areas such as Iraq, Somalia, Sudan, and Yemen.
Antimicrobial Resistance (AMR)
In MENA, 2019 estimates reported 255,676 deaths associated with AMR and 68,292 deaths directly attributable. Globally, AMR was linked to 4.95 million deaths and directly caused 1.27 million in 2019. This is a pressing threat requiring stewardship policies and stronger surveillance.
Conclusion
The Middle East faces a complex and evolving health landscape, marked by the simultaneous rise of noncommunicable diseases—such as diabetes, cardiovascular diseases, obesity, and mental health disorders—and the persistent threat of infectious and emerging diseases, including MERS, dengue, and antimicrobial resistance. Lifestyle changes, urbanization, climate impacts, and population movements have accelerated these trends. Tackling this dual burden requires a coordinated approach: preventive measures like early screenings and healthy lifestyle promotion; strengthened mental health and nutritional programs; enhanced disease surveillance; and robust antimicrobial stewardship. Only through integrated policies, cross-sector collaboration, and sustained investment can the region effectively reduce disease burdens and improve public health outcomes.